Home / Products / Cancer (Tumor) Cell Lines / EFE-184
EFE-184
Datasheet Protocol

EFE-184

Cat. No. ARC0186
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Uterus (endometrium)

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

EFE-184 is a cancer cell line of uterus (endometrium) carcinoma, isolated from metastatic; ascites.

Recommended Products

IMPA2 Knockout K562 Polyclonal Cells IMPA2 Knockout K562 Polyclonal Cells Cat. No. ARG20685 EML4 Knockout HT29 Polyclonal Cells EML4 Knockout HT29 Polyclonal Cells Cat. No. ARG14369 MYLK3 Knockout Hela Polyclonal Cells MYLK3 Knockout Hela Polyclonal Cells Cat. No. ARG8452 HEXIM2 Knockout Hela Polyclonal Cells HEXIM2 Knockout Hela Polyclonal Cells Cat. No. ARG25654 ARHGAP18 Knockout A549 Polyclonal Cells ARHGAP18 Knockout A549 Polyclonal Cells Cat. No. ARG31543 CYB5A Knockout AGS Polyclonal Cells CYB5A Knockout AGS Polyclonal Cells Cat. No. ARG2357
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Uterus (endometrium)
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
69 years
Sex of Donor:
Female
Derived From Site:
Metastatic; Ascites
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

MPG Knockout SK-HEP-1 Polyclonal Cells

MPG Knockout SK-HEP-1 Polyclonal Cells

Cat. No. ARG16060
 MAN2A2 Knockout Raji Polyclonal Cells

MAN2A2 Knockout Raji Polyclonal Cells

Cat. No. ARG0961
 CCN1 Knockout HaCaT Cell Line

CCN1 Knockout HaCaT Cell Line

Cat. No. ARG43778
 ATG16L1 Knockout Raji Polyclonal Cells

ATG16L1 Knockout Raji Polyclonal Cells

Cat. No. ARG21296
 JAK1 Knockout HT29 Polyclonal Cells

JAK1 Knockout HT29 Polyclonal Cells

Cat. No. ARG23322
 HDLBP Knockout HAP1 Polyclonal Cells

HDLBP Knockout HAP1 Polyclonal Cells

Cat. No. ARG27537